novo nordisk ceo on treating diabetes and obesity, and challenges facing the industry
Published 2 years ago • 5.1K plays • Length 6:13
Download video MP4
Download video MP3
Similar videos
-
2:16
how novo nordisk built an empire selling diabetes and weight-loss drugs
-
2:15:10
novo nordisk ceo lars jorgensen testifies before senate on weight loss drugs pricing — 9/24/24
-
5:26
dr. scot gottlieb on novo nodrisk's oral diabetes drug, future of weight-loss drugs
-
23:13
why novo nordisk’s drugs are anti-obesity game-changers: cnbc healthy returns summit 2023
-
2:09
novo nordisk ceo on safety concerns associated with off-label use of diabetes drugs
-
7:49
ozempic, mounjaro users talk about changes to family life after weight loss
-
5:48
with novo nordisk success, is there a "nokia risk" for denmark?
-
41:31
big pharma is fooling you again, and you don't even know it
-
24:07
the ceo behind ozempic, wegovy and europe's most valuable company
-
19:20
how ozempic and wegovy accidentally made novo nordisk a $400b company
-
2:17
diabetes increases dementia risk in adults younger than 50 — and more
-
1:56
novo nordisk boss on ozempic and eating disorder criticism, social media pressure
-
3:26
time100 most influential companies: novo nordisk
-
6:57
dr. scott gottlieb on obesity drug costs: expect to see continued price reductions
-
7:12
ozempic is a game-changer. here’s how it works.
-
13:20
the novo nordisk scientist behind ozempic, wegovy weight loss research
-
13:06
novo nordisk ceo on catalent, ozempic and wegovy
-
4:35
novo boosts profit outlook on obesity drug demand
-
4:26
novonordisk 'delivers 7% growth,' ceo says despite the impact of covid
-
5:27
novo nordisk ceo on q4 results, soaring demand for wegovy and ozempic
-
8:27
novo owner’s ceo on obesity sales boom, catalent deal
-
3:46
obesity product competition benefits companies and society: novo nordisk
Clip.africa.com - Privacy-policy